Anthony Pius Shen Buys 7,000 Shares of Vitalhub (TSE:VHI) Stock

Vitalhub Corp. (TSE:VHI) Director Anthony Pius Shen bought 7,000 shares of the business’s stock in a transaction that occurred on Monday, March 30th. The shares were acquired at an average price of C$7.11 per share, for a total transaction of C$49,770.00. Following the transaction, the director owned 12,470 shares in the company, valued at C$88,661.70. This represents a 127.97% increase in their ownership of the stock.

Vitalhub Price Performance

TSE VHI opened at C$6.98 on Wednesday. The business has a 50 day simple moving average of C$8.02 and a 200 day simple moving average of C$9.23. Vitalhub Corp. has a one year low of C$6.67 and a one year high of C$14.64. The stock has a market capitalization of C$441.36 million, a P/E ratio of 69.80, a P/E/G ratio of 1.18 and a beta of 0.65.

Vitalhub (TSE:VHI) last issued its quarterly earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share (EPS) for the quarter. The firm had revenue of C$31.39 million for the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%. Equities analysts expect that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on VHI. Raymond James Financial dropped their target price on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 24th. Scotiabank reduced their price target on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th. Royal Bank Of Canada decreased their price target on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a research note on Monday, January 26th. Finally, ATB Cormark Capital Markets dropped their price objective on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a report on Tuesday, March 10th. One investment analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of C$13.86.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.